We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ROCHE SELLS OTC BUSINESS TO BAYER; OTC XENICAL RIGHTS TO GSK
ROCHE SELLS OTC BUSINESS TO BAYER; OTC XENICAL RIGHTS TO GSK
July 19, 2004
Bayer has acquired the OTC drug business of Roche for approximately $2.96 billion, a transaction that makes the company one of the top three OTC businesses worldwide.